Syncom Formulations Submits FY26 BRSR Report

Syncom Formulations India Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report, filed pursuant to SEBI (LODR) Regulations, 2015, details the company's operations, employee data, and sustainability initiatives. The company is also preparing to file the BRSR in XBRL format and will make it available on its website. The report indicates that the company's primary business activity is the manufacture and sale of pharmaceuticals, accounting for 92.62% of its turnover. Exports constitute a significant portion of its revenue, with 82.94% of turnover coming from international sales.